A recent study from ASH 2024 examined the clinical features and outcomes of RT in British Columbia, comparing two eras: the chemoimmunotherapy (CIT) era (pre-2016) and the novel agents (NA) era (post-2016).
Read More
Educational programs and psychological support addressing cancer-related beliefs and promoting healthier coping strategies are crucial for improving outcomes.
Read More
A curated eBook featuring AAO 2024 retinal vascular disease-focused studies, findings, and expert opinions.
Read More
A curated eBook featuring CHEST 2024 RCC-focused studies, findings, and expert opinions.
Read More
A curated ebook on COPD featuring recent studies, findings, and opinions from thought leaders.
Read More
A curated ebook on tardive dyskinesia featuring recent studies, findings, and opinions from thought leaders.
Read More
Molecular residual disease was detected about six months before radiographic confirmation of recurrence in patients with inflammatory breast cancer.
Read More
A 69-year old patient from Southeast Asia presents with a 10-year history of cough and progressive dyspnea. The patient denies tobacco use or exposure.
Read More
Oncologist Marla Lipsyc-Sharf, MD, and colleagues will discuss treatment considerations in metastatic ER+ breast cancer at the 2024 SABCS meeting.
Read More
This roundup includes a selection of abstracts on early and metastatic breast cancer presented at the 2024 San Antonio Breast Cancer Symposium.
Read More
New research on breast cancer was presented at the San Antonio Breast Cancer Symposium 2024, including updates on HER2-enriched disease and lymphedema.
Read More
Will you be attending “Case Based Clinical Approach to ER Positive Metastatic Breast Cancer” on Wednesday, December 11?
Read More
Will you be attending “Mind the Gap — Breast Cancer in the Young” at SABCS?
Read More
Treatment resistance and toxicity remain critical challenges in managing chronic lymphocytic leukemia (CLL), according to researchers at the ASH Annual Meeting.
Read More
Oral oncolytic therapies have revolutionized the treatment of chronic lymphocytic leukemia (CLL), offering improved outcomes and convenience for patients.
Read More
Will you be attending the morning symposia, “Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia – What Clinicians Want to Know” at ASH?
Read More
A curated eBook featuring ESMO 2024 RCC-focused studies, findings, and expert opinions.
Read More
Do you remember the COPD research presented at CHEST 2024? Test your knowledge now and see how you rank!
Read More
The 2024 ASHP Midyear Clinical Meeting will feature multiple medical specialties, including infectious disease, diabetes, oncology, pain management, and more.
Read More
Will you be attending “The Upside of Imposter Syndrome” on Thursday, December 12, at ASHP?
Read More
